Join this insightful webinar on the innovative uses of master protocols in clinical trials. The master protocol approach is transforming the landscape of drug development by enabling the evaluation of multiple treatments across different disease states or patient populations within a single trial structure. An approach like this can offer significant advantages, including increased efficiency, faster decision-making and improved coordination, but poses challenges to operationalization without proper planning and support.
In this webinar, the featured speakers will explore the key aspects of master protocols, discuss benefits and challenges and provide practical insights into implementation and operationalization. Whether attendees are researchers, clinicians or part of the biopharma industry, this session will equip them with the knowledge to leverage master protocols effectively in clinical research.
Speakers
Beth Chamblin, Senior Director, Project Management, Late Phase Oncology, IQVIA Biotech
Beth Chamblin has 25 years of experience in pharmaceutical/biopharmaceutical development, including over 15 years in global clinical project management and four years in oncology project management. At IQVIA Biotech, she specializes in strategic oversight of late-phase global clinical programs, supporting emerging biotech companies. Beth has managed global Phase I-III studies across multiple regions and has expertise in novel trial designs. She also leads a team of 10 project managers/directors, providing mentoring and support. Her broad experience allows her to align each study with a company’s long-term goals, ensuring project success.
Message Presenter
Kelley Coalier, MS, MBA, Associate Principal, Enterprise Transformation Strategy, IQVIA
Kelley Coalier is a strategy consultant with 14 years of experience in the life sciences. She collaborates with biopharma, academia, government and nonprofits to foster innovative approaches and leverage cutting-edge technologies. Kelley has played a pivotal role in establishing public-private partnerships and supports streamlined decision-making and process efficiency in clinical development. Her diverse background enables her to optimize efficiencies and assess readiness for new capabilities, ensuring clients’ missions and visions are realized.
Message Presenter
Brad Smith, Vice President, Therapeutic Strategy, IQVIA
Brad Smith is the Vice President of Therapeutic Strategy, specializing in translational medicine. He is a recognized leader in biomarkers and companion diagnostics in clinical research, with expertise in technical, scientific, regulatory, legal and business aspects. Previously, Brad led Corporate Development at Cell Signaling Technology and managed the translational medicine lab. His scientific background includes research at Stanford University and UCSF, focusing on disease mechanisms. Brad holds a Doctoral degree from Stanford University and Master’s and Bachelor’s degrees from UC Santa Cruz.
Message PresenterWho Should Attend?
This panel-led webinar brings together trial design experts from IQVIA Biotech and IQVIA to focus on the practical uses of master protocols in clinical research. The speakers will explore how this approach can offer significant advantages, including increased efficiency, faster decision-making and improved coordination, and will also discuss the challenges to operationalization without proper planning and support.
This webinar is intended for C-suite and clinical development/operations executives in small, mid and large pharma and biotech companies.
What You Will Learn
Attendees will gain insights to:
- Understand the benefits, optimal use cases and best scenarios for master protocols
- Maximize trial operations with improved coordination and more sub-study opportunities
- Enhance data collection and sharing, broadening patient access to new therapies
- Navigate strategic relationships for safe and successful master protocol research
Xtalks Partner
IQVIA Biotech
IQVIA Biotech is a biotech-specialized CRO delivering flexible clinical development solutions for biotech and emerging biopharma companies. Our clinical solutions are built on 25 years of unmatched experience with therapeutically aligned expertise, uniquely designed to deliver full-service solutions on a global scale. Learn more at iqviabiotech.com.
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account